Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

Delayed Data
As of Nov 27
 +2.13 / +2.02%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals Inc have a median target of 144.00, with a high estimate of 184.00 and a low estimate of 107.00. The median estimate represents a +34.10% increase from the last price of 107.38.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Buy stock in Alnylam Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.40%
Growthannually 32.03%


Growthquarterly 48.25%
Growthannually -11.69%
Key to the earnings and sales forecast charts.